Chimeric Antigen Receptor Modified T Cells Directed Against CD19 (CTL019) in Patients with Poor Prognosis, Relapsed or Refractory CD19+ Follicular Lymphoma: Prolonged Remissions Relative to Antecedent Therapy
| Autor: | Chong, Elise A., Svoboda, Jakub, Nasta, Sunita Dwivedy *, Porter, David L., Winchell, Nicole *, Landsburg, Daniel J., Mato, Anthony R. *, Lacey, Simon F. *, Melenhorst, Jan J. *, Chew, Anne *, Hasskarl, Jens *, Marcucci, Katherine T. *, Levine, Bruce L, June, Carl H, Schuster, Stephen J. |
|---|---|
| Zdroj: | In Blood 2 December 2016 128(22):1100-1100 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|